image (51)

Having problems downloading?
Let us know here

Top 5 Unmissable Program Insights in 2024

  • Delve into harmonizing omics phenotyping spanning genetic mutations, variations in gene expression and gene-environment interactions to dissect molecular drivers of variability and explore optimal stratification with Tenaya
  • Leverage machine learning within large quantities of data to increase accuracy of risk identification for heart failure with Bayer
  • Navigate the heterogeneity of heart failure through phenotyping and pathobiology with Novartis
  • Streamline preclinical models from optimizing iPSCs, prioritizing human centric approaches and ensure robust in vivo modelling with Novo Nordisk & Pfizer
  • Tackle aging associated changes to activin signaling and gene expression signatures and in the heart Regeneron

Companies on the Program